27814657|t|Understanding ligand-receptor non-covalent binding kinetics using molecular modeling
27814657|a|Kinetic properties may serve as critical differentiators and predictors of drug efficacy and safety, in addition to the traditionally focused binding affinity. However the quantitative structure-kinetics relationship (QSKR) for modeling and ligand design is still poorly understood. This review provides an introduction to the kinetics of drug binding from a fundamental chemistry perspective. We focus on recent developments of computational tools and their applications to non-covalent binding kinetics.
27814657	14	29	ligand-receptor	UnknownType	C0683185
27814657	30	50	non-covalent binding	T044	C1167622
27814657	51	59	kinetics	T070	C0022702
27814657	66	84	molecular modeling	T062,T170	C0600115
27814657	85	103	Kinetic properties	T080	C0871161
27814657	126	141	differentiators	T169	C2945687
27814657	146	156	predictors	T078	C2698872
27814657	160	173	drug efficacy	T080	C0598333
27814657	178	184	safety	T080	C0678800
27814657	227	243	binding affinity	T044	C1167622
27814657	257	301	quantitative structure-kinetics relationship	T080	C0205556
27814657	303	307	QSKR	T080	C0205556
27814657	313	321	modeling	T062,T170	C0600115
27814657	326	332	ligand	T103	C0023688
27814657	333	339	design	T052	C1707689
27814657	349	355	poorly	T080	C0205251
27814657	356	366	understood	T041	C0162340
27814657	373	379	review	T170	C0282443
27814657	412	420	kinetics	T070	C0022702
27814657	424	428	drug	T121	C0013227
27814657	429	436	binding	T044	C1167622
27814657	456	477	chemistry perspective	T169	C0079107
27814657	491	497	recent	T079	C0332185
27814657	498	510	developments	T169	C1527148
27814657	514	533	computational tools	T170	C0037589
27814657	544	556	applications	T169	C0457083
27814657	560	580	non-covalent binding	T044	C1167622
27814657	581	589	kinetics	T070	C0022702